Authors: Terwee, CB Dekker, FW Mourits, MP Gerding, MN Baldeschi, L Kalmann, R Prummel, MF Wiersinga, WM

Citation: Cb. Terwee et al., Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments, CLIN ENDOCR, 54(3), 2001, pp. 391-398

Authors: Prummel, MF Gerding, MN Zonneveld, FW Wiersinga, WM

Citation: Mf. Prummel et al., The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy, CLIN ENDOCR, 54(2), 2001, pp. 205-209

Authors: Gerding, MN Prummel, MF Wiersinga, WM

Citation: Mn. Gerding et al., Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters, CLIN ENDOCR, 52(5), 2000, pp. 641-646

Authors: Gerding, MN van der Meer, JWC Broenink, M Bakker, O Wiersinga, WM Prummel, MF

Citation: Mn. Gerding et al., Association of thyrotrophin receptor antibodies with the clinical featuresof Graves' ophthalmopathy, CLIN ENDOCR, 52(3), 2000, pp. 267-271

Authors: Wakelkamp, IMMJ Gerding, MN Van Der Meer, JWC Prummel, MF Wiersinga, WM

Citation: Immj. Wakelkamp et al., Both Th1-and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy, CLIN EXP IM, 121(3), 2000, pp. 453-457

Authors: Terwee, CB Gerding, MN Dekker, FW Prummel, MF van der Pol, JP Wiersinga, WM

Citation: Cb. Terwee et al., Test-retest reliability of the GO-QOL: A disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy, J CLIN EPID, 52(9), 1999, pp. 875-884